Sign Up
Stories
Decongestants and Eye Drops: Ineffectiveness and Contamination
Share
Amgen and Pfizer Complete Acquisitions b...
Amgen to Lay Off Horizon Employees After...
Axsome's FDA Setback Sparks Investigatio...
Overview
API
Decongestants containing phenylephrine have been found to be ineffective, yet continue to be sold on pharmacy shelves. The FDA has warned against using certain over-the-counter eye drop products due to potential contamination. Teva Pharmaceutical Industries has reached a settlement agreement with Theravance Biopharma and Mylan Specialty for its inhalation drug Yupelri.
Ask a question
How can the effectiveness of decongestants be improved?
What are the potential implications of the settlement agreement for the pharmaceutical industry?
What measures can pharmacies take to ensure the safety of over-the-counter products?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jun 2023
Jul 2023
Aug 2023
Sep 2023
Oct 2023
Coverage